You are here:
NICE
NICE Guidance
Published Guidance
Trabectedin for the treatment of relapsed ovarian cancer
Technology appraisal guidance
Reference number:
TA222
Published:
27 April 2011
This guidance has been updated and replaced by
NICE technology appraisal guidance 389
.